UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012535 |
|---|---|
| Receipt number | R000013449 |
| Scientific Title | Multicenter phase II study of CapeOX (XELOX) with stop-and-go strategy as adjuvant chemotherapy in high-risk Stage II or Stage III colon and rectal cancer |
| Date of disclosure of the study information | 2013/12/09 |
| Last modified on | 2016/11/16 09:03:09 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/12/09 20:08:04 | ||
| 2 | Update | 2013/12/30 23:21:00 | Recruitment status |
|
| 3 | Update | 2016/06/28 12:37:57 | UMIN ID1 |
|
| 4 | Update | 2016/11/16 09:02:50 | Name of person sending information Name of person sending information Name of primary person or sponsor Organization |
|
| 5 | Update | 2016/11/16 09:03:09 | Recruitment status |
